3rd World Psoriasis & Psoriatic Arthritis Conference
Местоположение
3rd World Psoriasis & Psoriatic Arthritis Conference will take place in Stockholm, Sweden, between the dates June 27- July 1, 2012. The scientific program will also, as before, be strongly influenced by IFPA’s worldwide member survey, to ensure that the patient’s perspective is included. There will also be special seminars and side tracks for nurses, allied health professionals and others, who have a most important role in the care of psoriasis patients.
Scientific program:
| Wednesday June 27 | |
| Pre-Conference meetings Meetings of international research consortia and subcommittees. |
|
| 18.00 - 20.00
18.30 - 20.00 |
Registration for the conference opens at the Stockholm Waterfront Congress Centre Conference reception open for all delegates at the conference venue, floor 5. |
| Thursday June 28 | |
| 07.30 | Registration opens |
| 08.15 |
Opening ceremony
|
| 08.40 - 10.00
08.40 - 09.20 09.20 - 10.00
|
Psoriatic disease, skin and joint pathogenesis Chairs: Jörg Prinz, Dafna Gladman Molecular pathways to psoriatic skin inflammation Speaker: James Krueger Mechanisms of bone formation and destruction in psoriatic arthritis
|
| 10.00 - 10.20 |
Coffee/Posters/Exhibits
|
| 10.30 - 12.00
10.30 - 10.50 10.50 - 11.10 11.10 - 11.30 11.30 - 11.50 11.50 - 12.00
|
Psoriatic disease epidemiology Chairs: Jean-Hilaire Saurat, Philip Helliwell Disease associations in psoriasis: indicators of systemic inflammation? Psoriatic arthritis: Advances in phenotype and classification, what has changed since Psoriatic arthritis: Who has it, who gets it? Pustular psoriasis; what is it, what makes the difference? Abstract presentation |
| 12.00 - 13.30 |
Lunch/Posters/Exhibits |
| 12.15 - 13.15 | Industry-sponsored lunch seminar - Celgene |
| 13.30 - 15.30 13.30 - 14.00 14.00 - 14.20 14.20 - 14.40 14.40 - 15.00 15.00 - 15.20
15.20 - 15.30 |
Psoriatic disease around the world: ethnic, geographic and therapeutic considerations Chairs: Enno Christophers, Luis Espinosa The psoriatic phenotypes: a global perspective Psoriatic arthritis in Latin America: challenges in diagnosis and treatment Psoriasis in India: Clinical patterns and treatment challenges Psoriatic arthritis in South East Asia: disease characteristics and economic burden HIV and psoriasis: the African experience Abstract presentation
|
| 15.30 - 16.00 |
Coffee/Posters/Exhibits
|
| 16.00 - 16.30
|
Key note lecture: Inflammatory mediators in cardiovascular disease with relevance to psoriatic disease Chairs: Peter van de Kerkhof, Oliver FitzGerald Speaker: James De Lemos
|
| 16.45 - 17.45 | Industry-sponsored satellite symposium - Pfizer
|
| 19.00 | Welcome reception at the Stockholm City Hall By invitation of the City of Stockholm and the Stockholm City Council |
| Friday June 29 | |
|
07.15 - 08.15
|
Interesting psoriasis & psoriatic arthritis clinical cases Chair: Alan Menter Three interesting cases from around the world with active audience participation Panel chair: Dafna Gladman Panelists/presenters: Vermén Verallo-Rowell, André Carvalho, Philip Mease |
| 07.30 - 08.30 |
Posters/Exhibits |
| 08.30 - 10.00 08.30 - 08.50 08.50 - 09.10 09.10 - 09.25 09.25 - 09.40
09.40 - 10.00 |
Psoriatic disease genetics Chairs: Alan Menter, Philip Mease The genetics of psoriasis: old risks, novel loci Speaker: Anne Bowcock Are there genes that predispose psoriasis patients to psoriatic arthritis? Are skin and joints related? - Five key arguments against Panel discussion
|
| 10.00 - 10.30 |
Coffee/Posters/Exhibits |
| 10.30 - 12.00 10.30 - 10.50 10.50 - 11.10 11.10 - 11.30 11.30 - 11.50
11.50 - 12.00 |
Screening tools and outcome measures to assess psoriatic disease Chairs: Amit Garg, William Taylor Outcomes measures for psoriatic disease Speaker: Craig Leonardi Screening tools for psoriatic arthritis: The role of the dermatologist in early diagnosis Composite indices and integrated assessment across the psoriatic spectrum Imaging for the diagnosis of psoriatic arthritis: Which and when? Abstract presentation
|
| 12.00 - 13.30 |
Lunch/Posters/Exhibits |
| 12.15 - 13.15
|
Industry-sponsored lunch seminar - Janssen |
| 13.30 - 15.30 13.30 - 13.50 13.50 - 14.10 14.10 - 14.30 14.30 - 14.50 14.50 - 15.10 15.10 - 15.20 15.20 - 15.30 |
Psoriatic disease through the life cycle Chairs: Edgardo Chouela, Neil McHugh Depression, anxiety and coping: Is the impairment from psoriasis cumulative over a patient’s lifetime? Speaker: Alexa Kimball Therapeutic challenges for females of childbearing age Psoriasis in childhood and adolescence: clinical characteristics and treatment Late onset psoriatic arthritis: is it different? What do we know about the natural history of psoriasis? Abstract presentation Abstract presentation |
| 15.30 - 16.00 | Coffee/Posters/Exhibits
|
| 16.00 - 16.30 | Key note lecture: Inflammatory bowel disease and psoriasis: common genetic and pathogenetic pathways? Chairs: Ricardo Romiti, Ignazio Olivieri Speaker: Yehuda Chowers
|
| 16.45 - 17.45 | Industry-sponsored satellite symposium - Abbott International |
| 18.00 - 18.45 | Industry-sponsored satellite symposium - Novartis |
| 19.30 | Conference dinner at the Vasa Museum |
| Saturday June 30 | |
| 07.15 - 08.15 |
Industry-sponsored breakfast seminar - Eli Lilly Room C1-C3, level 2 |
| 07.30 - 08.30 |
Posters/Exhibits |
| 08.30 - 09.30 08.30 - 08.50 08.50 - 09.10 09.10 - 09.30
|
Psoriatic disease - pathogenic insights Chairs: Vermén Verallo-Rowell, Christopher Ritchlin The inflammasome and the alarmins: what starts psoriatic inflammation? Synovitis in psoriatic arthritis: what can immunohistochemistry tell us? What do T cells see in psoriasis lesions?
|
| 09.30 - 10.00
|
Key note lecture: Comparative Effectiveness Analysis and Pharmacoeconomic modelling of biologics in Psoriasis Chairs: Vermén Verallo-Rowell, Christopher Ritchlin Speaker: Aslam Anis
|
| 10.00 - 10.30
|
Coffee/Posters/Exhibits |
| 10.30 - 12.00 10.30 - 10.50 10.50 - 11.10 11.10 - 11.30 11.30 - 11.50
11.50 - 12.00 |
Systemic therapies in psoriatic disease Chairs: Gail Todd, Arthur Kavanaugh Methotrexate usage globally for psoriatic disease Speaker: Menno De Rie Do traditional DMARDs work in psoriatic arthritis? TNF antagonists in psoriatic arthritis TNFα antagonists and p40 antibodies in psoriasis: similarities and differences Abstract presentation |
| 12.00 - 13.30
|
Lunch/Posters/Exhibits |
| 12.15 - 13.15 |
Industry-sponsored lunch seminar - LEO Pharma |
| 13.30 - 15.00
13.30 - 13.50 13.50 - 14.10 14.10 - 14.30 14.30 - 14.50 14.50 - 15.00 |
Psoriasis and psoriatic arthritis: disease activity and therapeutic challenges Chairs: Mark Lebwohl, Ennio Lubrano Evaluation and treatment of psoriatic nail disease Speaker: Phoebe Rich Minimal disease activity in psoriatic arthritis: indicator of remission or potential Treatment algorithms and quality guidelines Body weight and treatment response Abstract presentation |
| 15.00 - 15.30 | Coffee/Posters/Exhibits
|
| 15.30 - 16.50
15.30 - 15.50 15.50 - 16.10 16.10 - 16.30 16.30 - 16.50 |
Concluding lectures Chairs: Mona Ståhle, Björn Guðbjörnsson Psoriatic disease care: a team approach Systemic therapy: does it affect cardiovascular risk? Psoriasis and the burden of disease: calling for worldwide action IFPA’s work for worldwide recognition of psoriasis as a serious noncommunicable disease |
| 16.50 - 17.00 | Closing of scientific program |
| Sunday July 1 |
| IFPA Member meeting and post-conference meetings. |
More information can be found on the official site of the Conference.
- Чтобы увидеть комментарии, войдите или зарегистрируйтесь
- Календарь
| © Дерматология в России, 2007-2026
|
О сайте | Правовая информация | |
| Материалы сайта предназначены только для врачей. По вопросам, касающимся Вашего здоровья, обратитесь к специалисту. 18+ | |||